Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

Thaker, Premal H.; Han, Liz Y.; Kamat, Aparna A.; Arevalo, Jesusa M.; Takahashi, Rie; Chunhua Lu; Jennings, Nicholas B.; Armaiz-Pena, Guillermo; Bankson, James A.; Ravoori, Murali; Merritt, William M.; Lin, Yvonne G.; Mangala, Lingegowda S.; Tae Jin Kim; Coleman, Robert L.; Landen, Charles N.; Yang Li; Felix, Edward; Sanguino, Angela M.; Newman, Robert A.
August 2006
Nature Medicine;Aug2006, Vol. 12 Issue 8, p939
Academic Journal
Stress can alter immunological, neurochemical and endocrinological functions, but its role in cancer progression is not well understood. Here, we show that chronic behavioral stress results in higher levels of tissue catecholamines, greater tumor burden and more invasive growth of ovarian carcinoma cells in an orthotopic mouse model. These effects are mediated primarily through activation of the tumor cell cyclic AMP (cAMP)–protein kinase A (PKA) signaling pathway by the β2 adrenergic receptor (encoded by ADRB2). Tumors in stressed animals showed markedly increased vascularization and enhanced expression of VEGF, MMP2 and MMP9, and we found that angiogenic processes mediated the effects of stress on tumor growth in vivo. These data identify β-adrenergic activation of the cAMP–PKA signaling pathway as a major mechanism by which behavioral stress can enhance tumor angiogenesis in vivo and thereby promote malignant cell growth. These data also suggest that blocking ADRB-mediated angiogenesis could have therapeutic implications for the management of ovarian cancer.


Related Articles

  • 772. Inhibition of Ovarian Tumor Growth Following Treatment with an Oncolytic Vaccinia Virus. Xiang Da (Eric) Dong; O'Malley, Mark E.; Chalikonda1, Sri; Zongsheng Guo; Zeh, Herbert J.; Bartlett, David L. // Molecular Therapy;Jun2006, Vol. 13, pS298 

    Background: Recombinant vaccinia virus is currently being explored as a potential replicating oncolytic virus for cancer virotherapy due to its exceptional ability to replicate in tumor cells. Vaccinia tropism is not limited to tumor tissues, but also other tissues including ovarian follicles,...

  • Synergistic effects of Pten loss and WNT/CTNNB1 signaling pathway activation in ovarian granulosa cell tumor development and progression. Marie-Noëlle Laguë; Marilène Paquet; Heng-Yu Fan; M. Johanna Kaartinen; Simon Chu; Soazik P. Jamin; Richard R. Behringer; Peter J. Fuller; Andrew Mitchell; Monique Doré; Louis M. Huneault; JoAnne S. Richards; Derek Boerboom // Carcinogenesis;Nov2008, Vol. 29 Issue 11, p2062 

    The mechanisms of granulosa cell tumor (GCT) development may involve the dysregulation of signaling pathways downstream of follicle-stimulating hormone, including the phosphoinosite-3 kinase (PI3K)/AKT pathway. To test this hypothesis, a genetically engineered mouse model was created to...

  • Sympathetic Neurotransmitters and Tumor Angiogenesis-Link between Stress and Cancer Progression. Tilan, Jason; Kitlinska, Joanna // Journal of Oncology;2010, p1 

    Recent evidence supports a longstanding hypothesis that chronic stress can influence tumor growth and progression. It has been shown that sympathetic neurotransmitters, such as catecholamines and neuropeptides, can affect both cancer cell growth and tumor vascularization. Depending on...

  • Transcriptional Regulation of PIK3CA Oncogene by NFκB in Ovarian Cancer Microenvironment. Nuo Yang; Jia Huang; Greshock, Joel; Shun Liang; Barchetti, Andrea; Hasegawa, Kosei; Kim, Sarah; Giannakakis, Antonis; Chunsheng Li; O'Brien-Jenkins, Anne; Katsaros, Dionyssios; Bützow, Ralf; Coukos, George; Lin Zhang // PLoS ONE;2008, Vol. 3 Issue 3, p1 

    PIK3CA upregulation, amplification and mutation have been widely reported in ovarian cancers and other tumors, which strongly suggests that PIK3CA is a promising therapeutic target. However, to date the mechanisms underlying PIK3CA regulation and activation in vivo is still unclear. During...

  • Assessment of anti-inflammatory tumor treatment efficacy by longitudinal monitoring employing sonographic micro morphology in a preclinical mouse model. Tiwari, Sanjay; Egberts, Jan H.; Korniienko, Olena; K�hler, Linda; Trauzold, Anna; Gl�er, Claus C.; Kalthoff, Holger // BMC Medical Imaging;2011, Vol. 11 Issue 1, p15 

    Background: With the development of increasingly sophisticated three-dimensional volumetric imaging methods, tumor volume can serve as a robust and reproducible measurement of drug efficacy. Since the use of molecularly targeted agents in the clinic will almost certainly involve combinations...

  • The Multifaceted Roles of Osteopontin in Cell Signaling, Tumor Progression and Angiogenesis. Chakraborty, Goutam; Jain, Shalini; Behera, Reeti; Ahmed, Mansoor; Sharma, Priyanka; Kumar, Vinit; Kundu, Gopal C. // Current Molecular Medicine;Dec2006, Vol. 6 Issue 8, p819 

    Osteopontin (OPN) is a chemokine like phosphorylated glycoprotein that plays important role in cancer progression. Extensive research from various laboratories has demonstrated the likely role of OPN in regulating the cell signaling that ultimately controls tumor growth and metastasis. Several...

  • Oscillatory dynamics in a model of vascular tumour growth - implications for chemotherapy. Stamper, I. J.; Owen, M. R.; Maini, P. K.; Byrne, H. M. // Biology Direct;2010, Vol. 5, p27 

    Background: Investigations of solid tumours suggest that vessel occlusion may occur when increased pressure from the tumour mass is exerted on the vessel walls. Since immature vessels are frequently found in tumours and may be particularly sensitive, such occlusion may impair tumour blood flow...

  • Classifying collective cancer cell invasion. Friedl, Peter; Locker, Joseph; Sahai, Erik; Segall, Jeffrey E. // Nature Cell Biology;Aug2012, Vol. 14 Issue 8, p777 

    The article focuses on collective invasion of cancer cells. It says that the ability of cancer cells to spread in adjacent tissue serves as a hallmark of cancer. It explores the categories of collective cancer cell invasion, such as single-cell migration, multicellular streaming, and collective...

  • Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis. Donald Wong; Kandagatla, Pridvi; Korz, Walter; Chinni, Sreenivasa R. // BMC Urology;2014, Vol. 14 Issue 1, p1 

    Background CXCL12/CXCR4 transactivation of epidermal growth factor family receptors in lipid raft membrane microdomains on cell surface is thought to mediate tumor growth and subsequent development of metastatic disease. CTCE-9908 is a known inhibitor of CXCR4. Herein, we tested the efficacy of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics